Orientin
Orientin may be regarded as a candidate therapeutic agent for treatment of vascular inflammatory diseases via inhibition of the HMGB1 signaling pathway.
Product Specifications
CAS Number
28608-75-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
448.38
Molecular Formula
C21H20O11
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog